Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$24.41
-0.4%
$26.63
$22.64
$53.96
$1.16B0.79465,504 shs460,186 shs
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
$13.55
+0.3%
$15.09
$9.58
$18.50
$444.25M0.25599,202 shs223,643 shs
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
$194.86
-0.6%
$197.54
$171.73
$244.98
$61.01B1.1229.66 million shs28.83 million shs
NVIDIA Co. stock logo
NVDA
NVIDIA
$108.92
-0.1%
$111.47
$81.25
$195.95
$2.66T1.96302.87 million shs229.38 million shs

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
-0.37%+3.61%-15.80%-32.88%-40.82%
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
+0.30%-3.21%-9.00%-25.71%-23.01%
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
-0.63%+2.42%-2.32%-14.73%-0.53%
NVIDIA Co. stock logo
NVDA
NVIDIA
-0.09%+6.08%+0.50%-12.69%+26.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
4.5062 of 5 stars
3.03.00.03.73.64.21.3
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
3.6253 of 5 stars
3.01.00.04.33.31.70.6
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/AN/AN/AN/AN/AN/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
4.874 of 5 stars
4.53.01.73.03.32.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
2.00
Hold$43.5078.21% Upside
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
2.00
Hold$18.4135.84% Upside
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
2.69
Moderate Buy$194.86N/A
NVIDIA Co. stock logo
NVDA
NVIDIA
2.93
Moderate Buy$164.9651.45% Upside

Current Analyst Ratings Breakdown

Latest IWM, NVDA, CCRN, and AMPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/25/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
4/25/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$162.00 ➝ $160.00
4/22/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$175.00 ➝ $155.00
4/17/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$185.00 ➝ $180.00
4/16/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy
4/16/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/16/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$220.00 ➝ $200.00
4/16/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00
4/16/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$175.00 ➝ $150.00
4/10/2025
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$731.97M1.58$3.40 per share7.17$13.35 per share1.83
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
$1.34B0.33$2.08 per share6.52$13.47 per share1.01
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/AN/AN/AN/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
$130.50B20.37$0.96 per share112.93$1.72 per share63.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$137.54M$3.068.147.422.1921.80%26.44%11.89%5/6/2025 (Estimated)
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
$72.63M-$0.43N/A25.093.32-0.12%5.38%3.84%5/7/2025 (Estimated)
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/AN/A15.40N/AN/AN/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
$29.76B$2.9442.8727.371.7655.69%114.83%76.61%5/28/2025 (Estimated)

Latest IWM, NVDA, CCRN, and AMPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q1 2026
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.87N/AN/AN/A$43.09 billionN/A
5/14/2025Q1 2025
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$0.66N/AN/AN/A$173.29 millionN/A
5/7/2025Q1 2025
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
$0.04N/AN/AN/A$314.82 millionN/A
2/26/2025Q4 2025
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.84$0.89+$0.05$0.89$38.16 billion$39.33 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
N/AN/AN/AN/AN/A
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
N/AN/AN/AN/AN/A
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
$2.471.27%N/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.040.04%+33.42%1.36%N/A

Latest IWM, NVDA, CCRN, and AMPH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
quarterly$0.010.03%3/12/20253/12/20254/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
0.82
3.43
2.61
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
N/A
2.79
2.79
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/AN/AN/A
NVIDIA Co. stock logo
NVDA
NVIDIA
0.13
4.10
3.64

Institutional Ownership

CompanyInstitutional Ownership
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
65.09%
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
96.03%
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/A
NVIDIA Co. stock logo
NVDA
NVIDIA
65.27%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
1,62047.50 million35.05 millionOptionable
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
2,70032.79 million31.21 millionOptionable
iShares Russell 2000 ETF stock logo
IWM
iShares Russell 2000 ETF
N/A313.10 millionN/ANot Optionable
NVIDIA Co. stock logo
NVDA
NVIDIA
26,20024.40 billion23.45 billionOptionable

Recent News About These Companies

Contrarian Investing 101: Why NVIDIA Isn’t Cheap at $100
Nvidia is still a buy, 'far ahead' of competitors: Analyst
Nvidia CEO calls for changes to US AI chip export restrictions
Nvidia CEO on AI: China is right behind us
NVIDIA Co. stock logo
Promising Technology Stocks To Watch Now - April 29th
NVIDIA Co. stock logo
Metaverse Stocks To Add to Your Watchlist - April 29th
Nvidia's Risk To Chinese Trade Restrictions May Be Easing
NVIDIA Co. stock logo
NVIDIA (NASDAQ:NVDA) Stock Price Down 0.1% - What's Next?
Why Nvidia Stock Is Falling Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amphastar Pharmaceuticals stock logo

Amphastar Pharmaceuticals NASDAQ:AMPH

$24.41 -0.09 (-0.37%)
As of 04/30/2025 04:00 PM Eastern

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Cross Country Healthcare stock logo

Cross Country Healthcare NASDAQ:CCRN

$13.55 +0.04 (+0.30%)
As of 04/30/2025 04:00 PM Eastern

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

iShares Russell 2000 ETF stock logo

iShares Russell 2000 ETF NYSEARCA:IWM

$194.86 -1.23 (-0.63%)
As of 04/30/2025 04:10 PM Eastern

iShares Russell 2000 ETF (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Russell 2000 Index (the Index). The Index is a float-adjusted capitalization weighted index that measures the performance of the small-capitalization sector of the United States equity market and includes securities issued by the approximately 2,000 smallest issuers in the Russell 3000 Index. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Index is a subset of the Russell 3000 Index, and serves as the underlying index for the Russell 2000 Growth and Value Index series. Component companies are adjusted for available float and must meet objective criteria for inclusion to the Index. The Fund's investment adviser is BlackRock Fund Advisors (BFA).

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$108.92 -0.10 (-0.09%)
As of 04/30/2025 04:00 PM Eastern

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.